论文部分内容阅读
目的 探讨巡能泰对急性脑梗死患者的疗效及安全性。方法 选取脑梗死症状发作 3天内住院的患者 ,给予巡能泰静脉注射 ,1周后再口服至 4周。治疗前后评估其神经功能及日常生活自我照顾能力并检查血液流变学。结果 共有 80例接受本研究 ,巡能泰药物治疗组 41例 ,对照组 39例。比较的结果 ,药物治疗组在神经功能的恢复比对照组多 ,但尚未达统计学上的意义。但在日常生活自我照顾能力及血液流变学则有显著意义的进步。结论 脑缺血症状发生后 3天内使用微循环促进剂—巡能泰 ,能改善患者之血液流变学 ,帮助神经功能及日常生活自我照顾功能的恢复。
Objective To investigate the efficacy and safety of Pao-tai-tai in patients with acute cerebral infarction. Methods Patients were hospitalized within 3 days after symptom onset of cerebral infarction. The patients were given intravenous injection and one week later they were orally taken for 4 weeks. Before and after treatment to assess their neurological function and self-care ability of daily life and check the blood rheology. Results A total of 80 patients accepted the study, patrols Thai medicine treatment group 41 cases, control group 39 cases. Compared with the control group, the drug treatment group recovered more neurological functions than the control group, but the results were not statistically significant. However, there is a significant improvement in self-care ability and hemorheology in daily life. Conclusions The microcirculation enhancer, PaoTailai, can improve the patients’ hemorrheology and help the recovery of neurological function and self-care function of daily life within 3 days after the occurrence of cerebral ischemia.